Subsequent validation in an independent cohort (GSE104948/GSE104954) refined this to a core three-gene signature (PDK4, RHCG, and FBP1), which demonstrated high diagnostic accuracy (AUCs > 0.8) in distinguishing DKD from controls (Fig 5A-5G, S1 Table). The gene discussed is FBP1; the disease is diabetic kidney disease.